Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/31/2025

Oral Estradiol Dosing for Menopausal Symptoms

Progestin Requirements

  • The American College of Obstetricians and Gynecologists recommends micronized progesterone (200 mg daily for 12-14 days every 28 days) as the first choice for progestin therapy in postmenopausal women with an intact uterus, with medroxyprogesterone acetate (10 mg daily for 12-14 days per month) as an alternative 1

Route of Administration Considerations

  • The North American Menopause Society prefers transdermal administration as it mimics physiological serum estradiol concentrations, provides a better safety profile than oral formulations, avoids hepatic first-pass effect, and has more beneficial effects on lipid profiles 1
  • When transdermal administration is contraindicated or refused, oral 17β-estradiol at doses of 1-2 mg daily can be used 1

Safety Considerations

  • The US Preventive Services Task Force recommends against using hormone therapy for the primary prevention of chronic conditions in postmenopausal women, with a grade D recommendation, indicating that the harms outweigh the benefits 2
  • The US Preventive Services Task Force recommends that hormone therapy should be used for symptom management rather than prevention of chronic conditions 2
  • The American College of Physicians suggests that hormone therapy should be used for the shortest duration consistent with treatment goals, with a moderate strength of evidence 3